The Significance of Exosomes in Pathogenesis, Diagnosis, and Treatment of Esophageal Cancer
Zhao Jing,Kai Chen,Ling Gong
DOI: https://doi.org/10.2147/ijn.s321555
IF: 7.033
2021-09-03
International Journal of Nanomedicine
Abstract:Zhao Jing, 1 Kai Chen, 2 Ling Gong 3 1 Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang, People's Republic of China; 2 Department of Cardiovascular and Thoracic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China; 3 Department of Infectious Disease (Liver Diseases), The Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang, People's Republic of China Correspondence: Zhao Jing Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang, People's Republic of China Tel +86-571-88091118 Email Esophageal cancer is one of the most common malignancy in China with high mortality. Understanding pathogenesis and identifying early diagnosis biomarkers can significantly improve the prognosis of patients with esophageal cancer. Exosomes are small vesicular structures containing a variety of components (including DNA, RNA, and proteins) mediating cell-to-cell material exchange and signal communication. Growing evidences have shown that exosomes and its components are involved in growth, metastasis and angiogenesis in cancer, and could also be used as diagnostic and prognostic markers. In this review, we summarized recent progress to elucidate the significance of exosomes in the esophageal cancer progression, microenvironment remodeling, therapeutic resistance, and immunosuppression. We also discuss the utility of exosomes as diagnostic and prognostic biomarkers and therapeutic tool in esophageal cancer. Keywords: exosome, esophageal cancer, biomarkers, liquid biopsy, prognosis Esophageal cancer (EC) is one of the most common diseases worldwide with high mortality. 1 China accounts for more than 50% of the world's newly diagnosed patients of EC. 2 Surgery is the cornerstone treatment for EC, with a median survival time of 13.6–19.3 months. 3 However, approximately 30% of newly diagnosed patients are suitable for curative resection. Although the multimodality treatment of EC has made significant progress in recent decades, the prognosis of patients still remains poor. There is no effective treatment method for the advanced patients. Early diagnosis can significantly reduce the mortality in patients with EC. It is urgently needed to identify the biomarkers to early diagnosis and accurately prognosis prediction of EC. Liquid biopsy allows detection of tumor-derived molecular biomarkers through biofluid sample with advantage of non-invasive, sensitive, and real-time analysis for early diagnosis and prognosis prediction. 4–6 Currently, circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (EVs) are the main targets of liquid biopsy. According to the size and pathway of generation, EVs are classified into exosomes, microvesicles (MVs), and apoptotic bodies. Exosomes are nano-sized (30–150nm) vesicles generated by the invagination of the plasma membrane. Exosomes have received tremendous attention in recent years because of convenient collection from most biofluids and the stability of cargoes. 7,8 Exosomes were first discovered in 1983 in serum medium. 9 Exosomes are 30–150 nm nanovesicles secreted from various cell types, containing lipids, proteins and nucleic acids. 10,11 Previous studies have shown that exosomes played important roles in cell-to-cell material exchange and signal communication. 7,12 Recently, exosomes are found to be participated in tumorigenesis and progression. 13,14 In this review, we summarize the significance of exosomes in the EC progression, microenvironment remodeling, therapeutic resistance, and immunosuppression. The utility of exosomes as EC diagnostic, prognostic and predictive biomarkers is reviewed. Furthermore, application of exosomes in the treatment of EC is also discussed. Exosomes play important roles in different stages of tumor development cascade (Figure 1) including tumor proliferation, angiogenesis, epithelial–mesenchymal transition (EMT), migration, microenvironment remodeling, and therapeutic resistance, which are described below (Table 1). Table 1 The Role of Exosomes in EC Figure 1 The role of exosomes in esophageal cancer. Exosomes mediate cell-cell and cell-microenvironment communication through transferring the biologically components (DNA, RNA, and proteins) as well as contribute to esophageal cancer progression by regulating angiogenesis, epithelial–mesenchymal transition (EMT), immune escape, microenvironment remodeling, and therapeutic resistance. Growing evidences demonstrated that exosomes could regulate the growth and metastasis of EC through secreting biologically active components. Tumor-derived exosomal miR -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology